Celgene's partnership with Bluebird & Juno

Discussion in 'Celgene' started by anonymous, Dec 11, 2017 at 12:10 PM.

Tags: Edit
  1. #1 anonymous, Dec 11, 2017 at 12:10 PM
    anonymous

    anonymous Guest

    Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017.

    I think it's an advantage for all the three companies involved; especially for Bluebird Bio.
     
    Quote

  2. #2 anonymous, Jun 3, 2018 at 6:41 PM
    anonymous

    anonymous Guest

    ASCO ‘18 not so impressive but very tough patient population. How will Wall Street react?
     
    Quote
  3. #3 anonymous, Jun 4, 2018 at 10:10 AM
    anonymous

    anonymous Guest

    ASH 2017???
     
    Quote
  4. #4 anonymous, Nov 18, 2018 at 1:50 PM
    anonymous

    anonymous Guest

    bluebird is a disorganized one trick pony with a extremely expensive treatment. Other biotech companies are catching up and everyone knows it
     
    Quote
Reply to Thread